Unlike ADPKD, in which almost all patients receive a genetic diagnosis indicating pathogenic variants in PKD1 and PKD2, the set of nine ADPLD-associated genes that have been recognized up to this point only explains 30–45% of the cases within the ADPLD population [16,24,25]. This evidence concerns the gene PKD1 and autosomal dominant polycystic liver disease.